LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Operating Expenses | 478 | 549 | 702 | 910 | 1,767 |
| Operating Income | -478 | -549 | -702 | -910 | -1,767 |
| Other Income | -6,029 | 1,882 | 480 | -2,194 | 0 |
| Pre-tax Income | -6,507 | 1,333 | -222 | -3,104 | -1,767 |
| Net Income Continuous | -6,507 | 1,333 | -222 | -3,104 | -1,767 |
| Net Income | $-6,509 | $1,333 | $-222 | $-3,104 | $-1,767 |
| EPS Basic Total Ops | -343.50 | 36,300.00 | -2,450.00 | -20,650.00 | -13,450.00 |
| EPS Basic Continuous Ops | -343.56 | 34,497.28 | -1,172.12 | -20,103.63 | -13,447.49 |
| EPS Diluted Total Ops | -343.50 | 36,300.00 | -2,450.00 | -20,650.00 | -13,450.00 |
| EPS Diluted Continuous Ops | -343.56 | 34,497.28 | -1,172.12 | -20,103.63 | -13,447.49 |
| EBITDA(a) | $-478 | $-549 | $-702 | $-910 | $-1,767 |